13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SC Filed 2023-05-23 Event — SEC 0001193125-23-151890 →

Pivotal bioVenture Partners Fund I, L.P. Inozyme Pharma, Inc.

Stake: Shares:

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
7 13D/G filings on this issuer
6 other filings besides this one
Filer Track Record
4 filings by this filer
3 other filings in the data moat
Short Interest
Not in latest FINRA snapshot

Other 13D/G Filings on Inozyme Pharma, Inc.

FiledFormFilerStakeShares
2025-08-27 SCHEDULE Pivotal bioVenture Partners Fund I, L.P. view →
2023-08-11 SC Longitude Capital Partners III, LLC view →
2023-04-04 SC Pivotal bioVenture Partners Fund I, L.P. view →
2021-03-30 SC Novo Holdings A/S view →
2021-02-01 SC Novo Holdings A/S view →
2020-10-05 SC Novo Holdings A/S view →

Other Filings by Pivotal bioVenture Partners Fund I, L.P.

FiledFormIssuerStakeShares
2025-08-27 SCHEDULE Inozyme Pharma, Inc. view →
2023-04-04 SC Inozyme Pharma, Inc. view →
2021-08-13 SC Bolt Biotherapeutics, Inc. BOLT view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →